BCL11A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.201000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.140400E-01
Normal-vs-Stage2
3.181400E-01
Normal-vs-Stage3
2.901600E-01
Normal-vs-Stage4
2.815000E-01
Stage1-vs-Stage2
7.739800E-01
Stage1-vs-Stage3
1.972590E-01
Stage1-vs-Stage4
8.408400E-02
Stage2-vs-Stage3
7.223800E-02
Stage2-vs-Stage4
2.456400E-02
Stage3-vs-Stage4
5.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.219000E-01
Normal-vs-AfricanAmerican
3.533600E-01
Normal-vs-Asian
2.978400E-01
Caucasian-vs-AfricanAmerican
6.448000E-02
Caucasian-vs-Asian
6.580300E-02
AfricanAmerican-vs-Asian
5.062200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.146600E-01
Normal-vs-Female
3.277800E-01
Male-vs-Female
3.787600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.155600E-01
Normal-vs-Age(41-60Yrs)
3.227200E-01
Normal-vs-Age(61-80Yrs)
3.196200E-01
Normal-vs-Age(81-100Yrs)
3.204000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.573400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.293600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.918200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.343600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.072400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.950400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.166400E-01
Normal-vs-Daily Drinker
3.208000E-01
Normal-vs-Weekly Drinker
2.831000E-01
Normal-vs-Occasional Drinker
3.291000E-01
Normal-vs-Social Drinker
3.377800E-01
Non Drinker-vs-Daily Drinker
8.549600E-01
Non Drinker-vs-Weekly Drinker
6.960300E-02
Non Drinker-vs-Occasional Drinker
6.995800E-01
Non Drinker-vs-Social Drinker
5.108800E-01
Daily Drinker-vs-Weekly Drinker
2.177500E-02
Daily Drinker-vs-Occasional Drinker
7.986200E-01
Daily Drinker-vs-Social Drinker
5.670600E-01
Weekly Drinker-vs-Occasional Drinker
8.782300E-02
Weekly Drinker-vs-Social Drinker
4.572500E-02
Occasional Drinker-vs-Social Drinker
8.157000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.332400E-01
Normal-vs-Grade 2
2.940600E-01
Normal-vs-Grade 3
2.804400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.755700E-02
Grade 1-vs-Grade 3
3.054400E-02
Grade 1-vs-Grade 4
3.332400E-01
Grade 2-vs-Grade 3
5.739600E-01
Grade 2-vs-Grade 4
2.940600E-01
Grade 3-vs-Grade 4
2.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.397000E-01
Normal-vs-NonDiabetic
3.117200E-01
Diabetic-vs-NonDiabetic
1.430440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.384400E-01
Normal-vs-NoPancreatitis
3.169400E-01
Pancreatitis-vs-NoPancreatitis
4.475800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.372200E-01
Normal-vs-N1
3.137800E-01
N0-vs-N1
2.705000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.765800E-01
Normal-vs-TP53-NonMutant
3.397000E-01
TP53-Mutant-vs-TP53-NonMutant
1.598010E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
